{
    "thread": {
        "uuid": "04556cfae00a412aca8a8e7beff2fde1ee03cf89",
        "url": "https://www.etfdailynews.com/2024/11/30/oragenics-nyseogen-now-covered-by-stocknews-com",
        "site_full": "www.etfdailynews.com",
        "site": "etfdailynews.com",
        "site_section": "https://www.etfdailynews.com",
        "site_categories": [],
        "section_title": "ETF Daily News",
        "title": "Oragenics (NYSE:OGEN) Now Covered by StockNews.com",
        "title_full": "Oragenics (NYSE:OGEN) Now Covered by StockNews.com",
        "published": "2024-11-30T08:56:00.000+02:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "US",
        "main_image": "",
        "performance_score": 0,
        "domain_rank": 53491,
        "domain_rank_updated": "2024-11-25T23:00:00.000+02:00",
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "04556cfae00a412aca8a8e7beff2fde1ee03cf89",
    "url": "https://www.etfdailynews.com/2024/11/30/oragenics-nyseogen-now-covered-by-stocknews-com",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "MarketBeat News",
    "published": "2024-11-30T08:56:00.000+02:00",
    "title": "Oragenics (NYSE:OGEN) Now Covered by StockNews.com",
    "text": "Investment analysts at StockNews.com started coverage on shares of Oragenics ( NYSE:OGEN – Get Free Report ) in a report released on Thursday. The firm set a “sell” rating on the stock.Shares of Oragenics stock opened at $0.32 on Thursday. The firm has a fifty day moving average of $0.34 and a two-hundred day moving average of $0.96. The stock has a market capitalization of $3.88 million, a price-to-earnings ratio of -0.04 and a beta of 0.49. Oragenics has a 52 week low of $0.25 and a 52 week high of $7.74. An institutional investor recently bought a new position in Oragenics stock. Virtu Financial LLC acquired a new stake in Oragenics, Inc. ( NYSE:OGEN – Free Report ) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 22,675 shares of the company’s stock, valued at approximately $33,000. Virtu Financial LLC owned approximately 0.51% of Oragenics as of its most recent SEC filing. 18.71% of the stock is currently owned by institutional investors. ( Get Free Report )Oragenics, Inc, a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
        "Labor",
        "Social Issue"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [
        "https://www.marketbeat.com/stocks/NYSE/OGEN/",
        "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=NYSE&Symbol=OGEN",
        "https://www.marketbeat.com/stocks/NYSE/OGEN/forecast/",
        "https://report.stocknews.com/sign-up/ticker/?ticker=OGEN&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=OGEN&utm_content=text_link",
        "https://www.report.stocknews.com/sign-up/ticker/?ticker=OGEN&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=OGEN&utm_content=text_link",
        "https://marketbeat.com/stocks/NYSE/OGEN/forecast/",
        "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx",
        "https://report.stocknews.com/sign-up/ticker/",
        "https://www.marketbeat.com/stocks/NYSE/OGEN/forecast",
        "https://marketbeat.com/stocks/NYSE/OGEN/",
        "https://www.marketbeat.com/stocks/NYSE/OGEN",
        "https://marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=NYSE&Symbol=OGEN"
    ],
    "external_images": [],
    "entities": {
        "persons": [],
        "organizations": [
            {
                "name": "Oragenics, Inc.",
                "sentiment": "neutral"
            },
            {
                "name": "Virtu Financial LLC",
                "sentiment": "none"
            },
            {
                "name": "SEC",
                "sentiment": "none"
            }
        ],
        "locations": []
    },
    "syndication": {
        "syndicated": false,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-11-30T10:30:49.208+02:00",
    "updated": "2024-11-30T10:30:49.208+02:00"
}